Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 5
2005 3
2006 2
2007 2
2009 2
2011 1
2013 2
2020 2
2021 7
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab.
Achiron A, Mandel M, Dreyer-Alster S, Magalashvili D, Menascu S, Warszawer Y, Dolev M, Didikin M, Harari G, Sonis P, Falb R, Gurevich M. Achiron A, et al. Among authors: mandel m. Mult Scler Relat Disord. 2023 Apr;72:104616. doi: 10.1016/j.msard.2023.104616. Epub 2023 Mar 12. Mult Scler Relat Disord. 2023. PMID: 36933299 Free PMC article.
Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis.
Menascu S, Siegel-Kirshenbaum M, Dreyer-Alster S, Warszawer Y, Magalashvili D, Dolev M, Mandel M, Harari G, Achiron A. Menascu S, et al. Among authors: mandel m. Mult Scler J Exp Transl Clin. 2023 Jan 17;9(1):20552173221151127. doi: 10.1177/20552173221151127. eCollection 2023 Jan-Mar. Mult Scler J Exp Transl Clin. 2023. PMID: 36687367 Free PMC article.
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod.
Achiron A, Mandel M, Gurevich M, Dreyer-Alster S, Magalashvili D, Sonis P, Dolev M, Menascu S, Harari G, Flechter S, Falb R. Achiron A, et al. Among authors: mandel m. J Neurol. 2022 May;269(5):2286-2292. doi: 10.1007/s00415-022-11030-0. Epub 2022 Mar 2. J Neurol. 2022. PMID: 35235002 Free PMC article. Clinical Trial.
COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose.
Dreyer-Alster S, Menascu S, Mandel M, Shirbint E, Magalashvili D, Dolev M, Flechter S, Givon U, Guber D, Stern Y, Miron S, Polliack M, Falb R, Sonis P, Gurevich M, Achiron A. Dreyer-Alster S, et al. Among authors: mandel m. J Neurol Sci. 2022 Mar 15;434:120155. doi: 10.1016/j.jns.2022.120155. Epub 2022 Jan 21. J Neurol Sci. 2022. PMID: 35091386 Free PMC article.
SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients.
Gurevich M, Zilkha-Falb R, Sonis P, Magalashvili D, Menascu S, Flechter S, Dolev M, Mandel M, Achiron A. Gurevich M, et al. Among authors: mandel m. Int J Infect Dis. 2022 Feb;115:208-214. doi: 10.1016/j.ijid.2021.12.309. Epub 2021 Dec 8. Int J Infect Dis. 2022. PMID: 34896265 Free PMC article.
36 results